Medidata Solutions

Medidata Solutions Inc. offers cloud-based solutions designed to enhance the clinical development programs of life sciences companies, including biopharmaceutical firms, device manufacturers, contract research organizations, and academic institutions. The company's primary revenue stream comes from subscriptions to the Medidata Clinical Cloud, which provides comprehensive tools for study design, data capture, patient engagement, risk-based monitoring, and financial management. Additionally, Medidata offers a range of services, including technology support and professional consulting, to assist clients in optimizing their clinical trials. By focusing on reducing trial cycle times and improving data visibility, Medidata Solutions aims to facilitate the efficient introduction of life-enhancing treatments to the market while maintaining fiscal responsibility.

Glen de Vries

Co-Founder

12 past transactions

Circuit Clinical

Venture Round in 2022
Circuit Clinical was born from the experiences of a physician conducting clinical research in his busy private practice. From the core belief that patients prefer to learn about clinical research from healthcare providers they trust, came the vision for Circuit Clinical. Since 2015 we've built one of the largest Integrated Research Organizations [IRO] in the US. Our focus on physician and participant engagement gives us a distinct advantage with the identification of motivated participants through direct HIPAA/FDA-compliant Electronic Medical Record (EMR) review. Coupled with our technology products that enhance the participant and physician experience, Circuit Clinical provides our network of more than 1 million patients, our physicians, and our sponsor partners with a new path forward in clinical research.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes develops a platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that enables patients to participate in treatment research online and benefit from their own medical data.

SHYFT

Acquisition in 2018
SHYFT Analytics, Inc. provides cloud-based data, analytics, and mobile solutions to the life sciences industry in the United States and internationally. It offers a cloud-based HTML5 mobile analytics application and data integration platform that helps life sciences companies to integrate clinical and commercial data, and translate it into patient-centric intelligence and analytics for use across functional groups to reduce cycle times across research, development, and commercialization activities. The company’s platform offers Sales solution that provides sales representatives with strategic and tactical insights, including operational alerts, patient compliance and persistency, SP scorecards, payer profiling, and more; and Specialty solution that provides pharmaceutical and biotechnology companies with integrated patient and prescriber data. Its platform also offers Launch solution that provides the market intelligence and commercial insights to support product launches; Rare Disease solution that unifies commercial and patient-centric data for stakeholder identification and management; Market Access solution that provides integrated payer analytics; and Real World Evidence (RWE), a cloud-enabled and mobile-ready solution that translates RWE data into patient-centric intelligence and guided analytics. In addition, the company offers services in the areas of launch and commercial analytics, clinical analytics and operations, insight driven design, sales strategies, and market access strategies. SHYFT Analytics, Inc. has a strategic partnership with PAREXEL International. SHYFT Analytics, Inc. was formerly known as Trinity Pharma Solutions, LLC and changed its name to SHYFT Analytics, Inc. in June 2015. The company was founded in 2002 and is based in Waltham, Massachusetts. SHYFT Analytics, Inc. operates as a subsidiary of Medidata Solutions, Inc.

Syapse

Series D in 2017
To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.

Mytrus

Acquisition in 2017
Mytrus is a San Francisco-based clinical technology and services company built on the idea that modern technologies can enable people to safely participate in clinical trials from the convenience of their own home, thereby improving accessibility, convenience and compliance, as well as cutting costs.

SHYFT

Series B in 2017
SHYFT Analytics, Inc. provides cloud-based data, analytics, and mobile solutions to the life sciences industry in the United States and internationally. It offers a cloud-based HTML5 mobile analytics application and data integration platform that helps life sciences companies to integrate clinical and commercial data, and translate it into patient-centric intelligence and analytics for use across functional groups to reduce cycle times across research, development, and commercialization activities. The company’s platform offers Sales solution that provides sales representatives with strategic and tactical insights, including operational alerts, patient compliance and persistency, SP scorecards, payer profiling, and more; and Specialty solution that provides pharmaceutical and biotechnology companies with integrated patient and prescriber data. Its platform also offers Launch solution that provides the market intelligence and commercial insights to support product launches; Rare Disease solution that unifies commercial and patient-centric data for stakeholder identification and management; Market Access solution that provides integrated payer analytics; and Real World Evidence (RWE), a cloud-enabled and mobile-ready solution that translates RWE data into patient-centric intelligence and guided analytics. In addition, the company offers services in the areas of launch and commercial analytics, clinical analytics and operations, insight driven design, sales strategies, and market access strategies. SHYFT Analytics, Inc. has a strategic partnership with PAREXEL International. SHYFT Analytics, Inc. was formerly known as Trinity Pharma Solutions, LLC and changed its name to SHYFT Analytics, Inc. in June 2015. The company was founded in 2002 and is based in Waltham, Massachusetts. SHYFT Analytics, Inc. operates as a subsidiary of Medidata Solutions, Inc.

CHITA

Acquisition in 2017
CHITA is a unified content integrity and collaboration platform for the modern digital workplace in Life Sciences.

SHYFT

Series B in 2016
SHYFT Analytics, Inc. provides cloud-based data, analytics, and mobile solutions to the life sciences industry in the United States and internationally. It offers a cloud-based HTML5 mobile analytics application and data integration platform that helps life sciences companies to integrate clinical and commercial data, and translate it into patient-centric intelligence and analytics for use across functional groups to reduce cycle times across research, development, and commercialization activities. The company’s platform offers Sales solution that provides sales representatives with strategic and tactical insights, including operational alerts, patient compliance and persistency, SP scorecards, payer profiling, and more; and Specialty solution that provides pharmaceutical and biotechnology companies with integrated patient and prescriber data. Its platform also offers Launch solution that provides the market intelligence and commercial insights to support product launches; Rare Disease solution that unifies commercial and patient-centric data for stakeholder identification and management; Market Access solution that provides integrated payer analytics; and Real World Evidence (RWE), a cloud-enabled and mobile-ready solution that translates RWE data into patient-centric intelligence and guided analytics. In addition, the company offers services in the areas of launch and commercial analytics, clinical analytics and operations, insight driven design, sales strategies, and market access strategies. SHYFT Analytics, Inc. has a strategic partnership with PAREXEL International. SHYFT Analytics, Inc. was formerly known as Trinity Pharma Solutions, LLC and changed its name to SHYFT Analytics, Inc. in June 2015. The company was founded in 2002 and is based in Waltham, Massachusetts. SHYFT Analytics, Inc. operates as a subsidiary of Medidata Solutions, Inc.

Intelemage LLC

Acquisition in 2016
Intelemage is currently powering the medical image and clinical data collaboration activities for medical device and pharmaceutical companies, core labs, CROs, hospitals, and physicians. Intelemage is trusted by many large well-known institutions and professionals including: Fortune 500 pharmaceutical and medical device companies, prestigious hospitals and healthcare facilities, top surgeons and radiologists, and professional sports leagues and teams.

Clinical Force

Acquisition in 2011
Clinical Force is a privately-held company with a strong life science pedigree and offices in the US and Europe. They deliver a fully functional Clinical Trials Management System (CTMS) deployed in four continents. Clinical Force has extensive experience in CROs and sponsors. Their visibility of 'both sides of the table' means that they have a solution that can join sponsors and their partners together.

Fast Track

Acquisition in 2008
Fast Track: a completely new and comprehensive approach to the way clinical trials are managed. The company is assembling a creative and energetic staff of technical and medical professionals, an experienced management team, industry-specific advisory boards, and an active investor constituency - all aggressively focused on achieving their vision: to revolutionize the management of clinical trials.

Medidata

Venture Round in 2002
Medidata is an unified life science platform. They help generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Their products and solutions include clinical cloud, patient cloud, decenteralized clinical trials, and more.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.